AgilVax Appoints Dr. Joseph Patti as Chief Executive Officer
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–#biotech–AgilVax Inc., a biopharmaceutical company developing targeted antibody-based products to treat multiple types of cancer in combination with…
Pharmaceuticals, Biotechnology and Life Sciences
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–#biotech–AgilVax Inc., a biopharmaceutical company developing targeted antibody-based products to treat multiple types of cancer in combination with…
DUBLIN–(BUSINESS WIRE)–The “Global Knee Osteoarthritis Market [By Treatment – Non-Surgical Treatment (NSAIDS, Corticosteroids, Hyaluronic Acid Injections & Alternate Therapies) &…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
MGH will have guaranteed access to ElevateBio BaseCamp’s expert scientists, operators and facilities to accelerate the development of cell and…
Increases Second Quarter Revenues 10% to $6.3 Billion Posts Second Quarter GAAP EPS of $0.87 and Non-GAAP EPS of $1.18…
Company Aligns with FDA on Planned Confirmatory Study Design for Tazemetostat in Epithelioid Sarcoma Company to Host Conference Call Today,…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global psoriatic arthritis therapeutics market is expected to post a CAGR of close to 9% during the period…
Quarterly net revenues of $86.7 million, representing 41 percent growth versus the second quarter 2018 The NovoTTF-100L™ System FDA approved…
LONDON–(BUSINESS WIRE)–#Healthcare–The prevalence of vascular disease has increased at a significant rate over the years, which is fueling the demand…
LONDON–(BUSINESS WIRE)–ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today…